Journal
ACTA PHARMACOLOGICA SINICA
Volume 34, Issue 12, Pages 1485-1490Publisher
ACTA PHARMACOLOGICA SINICA
DOI: 10.1038/aps.2013.160
Keywords
progesterone; traumatic brain injury; neuroprotection; hormone
Funding
- Key Medical Research platform Program of Zhejiang Province, China [2013ZDA019]
- Key Science and Technology Development Program of Hangzhou, China [20100733Q07]
Ask authors/readers for more resources
Traumatic brain injury is the leading cause of morbidity and mortality in young adults. The secondary injury in traumatic brain injury consists of a complex cascade of processes that simultaneously react to the primary injury to the brain. This cascade has been the target of numerous therapeutic agents investigated over the last 30 years, but no neuroprotective treatment option is currently available that improve neurological outcome after traumatic brain injury. Progesterone has long been considered merely a female reproductive hormone. Numerous studies, however, show that progesterone has substantial pleiotropic properties as a neuroprotective agent in both animal models and humans. Here, we review the increasing evidence that progesterone can act as a neuroprotective agent to treat traumatic brain injury and the mechanisms underlying these effects. Additionally, we discuss the current progress of clinical studies on the application of progesterone in the treatment of traumatic brain injuries.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available